Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 784 results found. Search for [ US FDA ]

Results 1 to 21 of 784
Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


BusinessToday.In
October 21, 2020
Coronavirus vaccine news: Britain will help fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of vaccines against it


BusinessToday.In
October 21, 2020
AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill


BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


BusinessToday.In
October 20, 2020
India Stock Market Highlights Today: HCL Tech, followed by L&T, M&M, Tech Mahindra, Maruti, TCS, Asian Paints, Infosys and HDFC Bank were among the top gainers today. On the other hand, ONGC, Nestle India, SBI, ICICI Bank and IndusInd Bank were among the laggards


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


BusinessToday.In
October 15, 2020
According to World Health Organisation's chief scientist, Dr Soumya Swaminathan said, health workers, elderly and frontline workers might get the COVID-19 vaccine first, though the prioritisation details are still being worked out by the WHO


BusinessToday.In
October 13, 2020
Stocks to watch today on October 13: RIL, Wipro, Godrej Properties, Infosys, Cipla, Lakshmi Vilas Bank among others are the top stocks to watch out for in Tuesday's trading session


PB Jayakumar
October 8, 2020
Cipla's research and development department is working on a couple of therapies that can be used in the treatment of COVID-19 and it could consider entering into marketing collaborations with companies that are currently developing vaccines for COVID-19


Reuters
October 8, 2020
Several European countries have said they are experiencing shortages of the drug, whose global stock has been secured almost entirely by the United States


BusinessToday.In
October 8, 2020
Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail


Associated Press
October 7, 2020
The Treasury and Health Departments developed economic modelling based on an assumption that a vaccine would be widely available in Australia toward the end of next year, Treasurer Josh Frydenberg said


Reuters
October 7, 2020
The FDA released the guidance laying out more stringent recommendations for drugmakers hoping to apply for an emergency use authorization (EUA) for their experimental vaccines


Associated Press
October 6, 2020
FDA Commissioner Stephen Hahn has pledged that career scientists, not politicians, will decide whether any coronavirus vaccine meets clearly stated standards that it works and is safe


PTI
October 2, 2020
In general experts seem to believe that a publicly available vaccine next summer is the best-case scenario with the possibility that it may take until 2022


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Reuters
October 1, 2020
AstraZeneca's large, late-stage U.S. trial has remained on hold since Sept. 6, after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis


PAGES 1 OF 40  12345